 |
| January
9, 2026 |
| Covering
Life Sciences Drugs, Diagnostics, Devices,
Digital Health |
|
|
|
* may need subscription to view |
 |
 |
| Boston's
most flexible contract vivarium
lab space: Start with a few study
cages and grow. |
|
Learn More
→ |
|
|
- Biofrontera: Data Base Locks for Two
Clinical Studies Supporting Key Data and
Regulatory Milestones More
- Boltz and Pfizer: Strategic Collaboration to
Develop and Deploy State-of-the-Art
Biomolecular AI Foundation Models More
- Butterfly Medical: Completion of Pivotal
Trial for Minimally Invasive Treatment of
Benign Prostatic Hyperplasia More
- Dana-Farber Cancer Institute: Researchers
Discover How Major Nuclear Protein Complexes
Control Specialized Gene Regulation in Cancer
and Beyond More
- Dewpoint Therapeutics: TDP-43 Condensate
Modulator Development Candidate for Treatment
of ALS and Related Neurodegenerative Diseases
More
- Elucid: Broad Reimbursement for Quantitative
Coronary Plaque Analysis More
- GC Therapeutics: Appoints Kate Haviland as
Board Chair and Provides Corporate Update More
- Nona Biosciences: Enters Into Collaboration
Agreement With Link Cell Therapies to Advance
CAR-T Cell Therapies More
- Ocular Therapeutix: Plans to Accelerate NDA
Submission Timeline for AXPAXLI in Wet AMD More
More*
- Praxis Precision Medicines: Further
Positioned for Next-Phase Growth With Key
Board and Executive Appointments More
- Quanterix: Appoints Everett Cunningham as
President and CEO Effective January 19, 2026
More
- Revvity: Collaborates With Lilly to Expand
Access to AI Drug Discovery Models More
- Tango Therapeutics: CEO Transition:
Barbara Weber to Retire, Malte Peters
Appointed Successor More
- Tessera Therapeutics: Chief Financial
Officer (CFO) Transition and Appointment of
Kathy Bergsteinsson as CFO More
- uniQure:
Type A Meeting Scheduled With FDA More
- ZOLL: Strengthens Growth Trajectory for
Asahi Kasei’s Healthcare Sector With U.S.
Launch of the Next-Generation LifeVest WCD and
Rollout of the Most Comfortable LifeVest
Garment Ever, Reinforcing Position as Leader
in WCD Category More
|
|
 |
The
Charles River CFO Advantage
Reassessing your business plan?
We provide financial leadership.
Smart. Nimble. Flexible. |
|
Learn More
→ |
|
|
|
- After Shaky Years, Mass. Life Science
Companies Find Glimmers of Hope More*
- Ardelyx: Preliminary 2025 Revenue and 2026
Strategic Outlook
More
- Aurora Therapeutics: Launches to Realize
Potential of Personalized Gene Editing for
Millions of Patients with Rare Diseases More
More*
- Bain Capital’s Adam Koppel on Private
Equity’s Role in Biotech More
- $780M in Funding Announced at Local
Biotechs in Lead-Up to JPMorgan Conference More*
- Exclusive: Medipost Raises $140M to Take
Korean Stem Cell Therapy Into US More*
- Get Full Access to BYTE51 Life Sciences
Intelligence for 50% Off More
- JPM
Week Conference Readiness Packages (Big4Bio
Subscriber Discount) More
- KalVista Pharmaceuticals: Update on Strong
EKTERLY Launch With Preliminary Fourth Quarter
and Full Year 2025 Revenue Results More
- Monte Rosa Therapeutics: Pricing of $300
Million Underwritten Public Offering More
- More on Aktis Raising $318M in 2026’s
First Biotech IPO More
More
More*
More*
- More on Flagship-Founded Tessera Planning to
Lay Off 90 Employees in March More
More*
- More on Parabilis Medicines Raises $305
Million as CEO Warms to an IPO More*
More
- More on Poplar’s $50 Million Series A to
‘Transform Treatment of Atopic Diseases’ More*
- Muna Therapeutics: Awarded $1 Million
Alzheimer’s Association Grant to Advance
Clinical Development of Novel Oral TREM2
Agonist MNA-001 for Alzheimer’s More
- Rhythm Pharmaceuticals: Preliminary,
Unaudited Fourth Quarter and Full Year 2025
Net Product Revenues and Upcoming Milestones More
- Spyre Therapeutics: Grants of Inducement
Awards More
- Ukko: 2026 Strategic Outlook and Recent
Milestones More
- Viridian Therapeutics: Inducement Grants
Under Nasdaq Listing Rule 5635(c)(4) More
- Xilio Therapeutics: Upcoming Milestones and
Recent Corporate Updates More
|
|
 |
 |
Pace®
Life Sciences
The CDMO That Takes You Further.
Your partner for Product
Development, Manufacturing,
Analytical Testing, Regulatory
Consulting & Operational
Support. |
|
Learn More
→ |
|
|
|
- Alexion Explores Complement Cascade to
Defend C5 Leadership More*
- BioPharmGuy News: Website Archaeology, Magic
Pills, Sickness is Health, Reverse Food Funnel
More
- Following the Science to Immunology: Kate
Haviland on The Long Run Podcast
- More on Charles River Labs CEO Retiring in
2026 After 30+ Years at the Helm More*
More*
More
- Subscribe to LifeSci Startup for
Updates on US Startups More
- The Big4Bio Podcast: Biotech
Showcase Readies as Biotech Stocks and Deals
Pick Up Podcast
- The Big4Bio Podcast: Every Moment
Matters: DMPK’s Role in Making Better Drugs
and Better Decisions Podcast
|
|
|
DISCOVER COMPANIES |
|
Big4Bio: Boston Life Science
Company Directory |
|
Locate a specific company or
explore new companies in life
science. |
|
Explore
our Company Directory
|
Provided courtesy
of
 |
|
|
|
Feature your company |
| Apply
to have your company
showcased by Big4Bio |
|
|
|
|
|
 |
|
Premier Executive Search and
Talent Advisory Firm Slone
Partners Launches Fractional
Talent Service to Deliver
On-Demand Leaders and Specialists
|
|
Learn More
→ |
|
|
- AI in Biotech: The New Frontier for
Leadership & Strategy More
- How Industry Trends are Impacting Hiring
Decisions and Leadership Strategies in Life
Sciences More
- M&A in Life Sciences: The Turning Tide –
Why Now is a Strategic Inflection for
Biopharma and Biotech More
- ICYMI: CEO’s Perspective: Big Moves Come
with Big Responsibility More
- ICYMI: CEO’s Perspective: The High Cost of
Job Hopping More
- ICYMI: Elevating Executive Presence: A
Blueprint for Life Sciences and Biotech
Leaders More
- ICYMI: The Power of Peer Learning - Why Even
Top Biotech Leaders Need Mentorship More
- ICYMI: What’s Next in Precision Medicine:
Leadership Challenges and Opportunities More
- The Rise of Fractional Talent in Life
Sciences: What to Expect in 2026 More
|
|
 |
|
|
|
You are
receiving this email because
you signed up for one of our
newsletters at Big4Bio.com,
signed up at one of our
partner or sponsor events,
or given as a gift
subscription by your firm or
organization. Unsubscribe
Big4Bio:Boston,
all rights reserved 2026
© 2026
Big4Bio, a division of
BigBio Communications. All
rights reserved.
|
|
|
|
|
